These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1283769)

  • 1. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk.
    Julius S; Gudbrandsson T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S40-8. PubMed ID: 1283769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question.
    Julius S; Jamerson K
    J Hypertens; 1994 May; 12(5):495-502. PubMed ID: 7930548
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system.
    Landsberg L
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S1-8. PubMed ID: 7519690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic neural activity in hypertension and related diseases.
    Grassi G
    Am J Hypertens; 2010 Oct; 23(10):1052-60. PubMed ID: 20651696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical consequences of the autonomic imbalance in hypertension and congestive heart failure.
    Julius S; Nesbitt S
    Scand Cardiovasc J Suppl; 1998; 47():23-30. PubMed ID: 9540130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and coronary heart disease.
    Baguet JP; Mallion JM
    Blood Press; 2003; 12(4):255-6. PubMed ID: 14596363
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of the sympathetic nervous system in essential arterial hypertension and organ damage].
    Grassi G; Mancia G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():115S-120S. PubMed ID: 8562257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension: a new perspective in therapy and metabolic effect. Part I.
    Medina Ruiz A
    Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin, nitric oxide and the sympathetic nervous system: from crossroads to metabolic and cardiovascular homeostasis].
    Sartori C; Thalmann S; Jayet PY; Duplain H; Vollenweider P; Scherrer U
    Rev Med Suisse Romande; 2004 Oct; 124(10):635-8. PubMed ID: 15573509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in hypertension--a relationship with consequences?
    Berne C
    J Intern Med Suppl; 1991; 735():65-73. PubMed ID: 2043224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension.
    Lembo G; Napoli R; Capaldo B; Rendina V; Iaccarino G; Volpe M; Trimarco B; Saccà L
    J Clin Invest; 1992 Jul; 90(1):24-9. PubMed ID: 1634611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in essential hypertension: a psychophysiological approach to the "chicken and egg" question.
    Nazzaro P; Triggiani R; Ciancio L; Scarano AM; Pirrelli AM
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):275-86. PubMed ID: 11213537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and insulin resistance.
    Prichard BN; Smith CC; Sen S; Betteridge DJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S77-84. PubMed ID: 1284147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing face of sympathetic overactivity in hypertension.
    Julius S; Majahalme S
    Ann Med; 2000 Jul; 32(5):365-70. PubMed ID: 10949068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention trials and role of vascular factors in moderate arterial hypertension].
    Safar M
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():23-7. PubMed ID: 3113394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and the sympathetic nervous system.
    Grassi G; Cattaneo BM; Seravalle G; Colombo M; Cavagnini F; Mancia G
    Blood Press Suppl; 1996; 1():43-6. PubMed ID: 9162437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.